New study shows people with schizophrenia are dying younger
Centre for Addiction and Mental Health News Sep 24, 2017
Poorer physical health care over their lifespan a leading cause.
People with schizophrenia have a mortality rate that is three times greater each year than those without schizophrenia, and die on average, eight years earlier than people without schizophrenia according to a new Ontario study by researchers at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
This study was published in the Canadian Medical Association Journal.
ÂOur study shows that individuals with schizophrenia are not benefitting from public health and health care interventions to the same degree as individuals without schizophrenia, said Dr. Paul Kurdyak, senior author, CAMH and ICES Scientist and Director of Health Outcomes with the Medical Psychiatry Alliance (MPA), which supported the study. ÂAs health care providers, it is our responsibility to work together across our health care system to provide these patients with better, integrated physical and mental health care. By not doing so, there are dire, tragic consequences and shortened lives.Â
Researchers studied all deaths during the 20-year period between 1993 and 2012 in Ontario and examined the deaths annually. They identified all people with schizophrenia and categorized the deaths as occurring among those with and without schizophrenia.
The study showed that individuals with schizophrenia had higher rates of death for all causes including cardiovascular diseases and chronic medical conditions.
While the rest of Ontario has experienced a reduction in cardiovascular deaths, the study shows that individuals with schizophrenia are not experiencing the same reduction.
People with schizophrenia have many cardiovascular risk factors such as diabetes, obesity, smoking and sedentary lifestyle, but are more burdened by these risk factors than those without schizophrenia. Medications used to treat schizophrenia can cause weight gain and the development of diabetes.
ÂIt seems that people with schizophrenia havenÂt benefitted from the advances that we have made for patients living with chronic physical illnesses in the general population, said Dr. Kurdyak. ÂA health care system that can address the mortality gap we have observed in this study would truly be a high performing health care system.Â
Go to Original
People with schizophrenia have a mortality rate that is three times greater each year than those without schizophrenia, and die on average, eight years earlier than people without schizophrenia according to a new Ontario study by researchers at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
This study was published in the Canadian Medical Association Journal.
ÂOur study shows that individuals with schizophrenia are not benefitting from public health and health care interventions to the same degree as individuals without schizophrenia, said Dr. Paul Kurdyak, senior author, CAMH and ICES Scientist and Director of Health Outcomes with the Medical Psychiatry Alliance (MPA), which supported the study. ÂAs health care providers, it is our responsibility to work together across our health care system to provide these patients with better, integrated physical and mental health care. By not doing so, there are dire, tragic consequences and shortened lives.Â
Researchers studied all deaths during the 20-year period between 1993 and 2012 in Ontario and examined the deaths annually. They identified all people with schizophrenia and categorized the deaths as occurring among those with and without schizophrenia.
The study showed that individuals with schizophrenia had higher rates of death for all causes including cardiovascular diseases and chronic medical conditions.
While the rest of Ontario has experienced a reduction in cardiovascular deaths, the study shows that individuals with schizophrenia are not experiencing the same reduction.
People with schizophrenia have many cardiovascular risk factors such as diabetes, obesity, smoking and sedentary lifestyle, but are more burdened by these risk factors than those without schizophrenia. Medications used to treat schizophrenia can cause weight gain and the development of diabetes.
ÂIt seems that people with schizophrenia havenÂt benefitted from the advances that we have made for patients living with chronic physical illnesses in the general population, said Dr. Kurdyak. ÂA health care system that can address the mortality gap we have observed in this study would truly be a high performing health care system.Â
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries